EUVIMEDEUVIMED entdecken
Crossref

Olea europaea L. cv. Nepal Leaf Extract Alleviates Dyslipidemia and Inflammation Related to Obesity in Rabbits: A Network Pharmacology Approach Revealing Effective Antihyperlipidemic Bioactive Compounds

Faisal Alsenani iD, Abeer H Elmaidomy iD, Rania Alaaeldin iD, Nehad M Reda Abdel-Maqsoud iD, Faisal H Altemani iD, Naseh A Algehainy iD, Mubarak A Alzubaidi iD, Hussain T Bakhsh iD, Fatma Alzahraa Mokhtar iD, Mahmoud A Elrehany iD, Ahmed M Sayed iD, Mohammad M Al-Sanea iD und 3 weitere

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202402110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Faisal Alsenani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. Hauptthemen laut MEDLINE: Dyslipidemias, Hypolipidemic Agents, Inflammation, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current study investigated the effects of Olea europaea L. cv. Nepal (OEN) leaf extract on obesity‐related disorders in rabbits. OEN extract, in dose 100 mg/kg body weight, significantly reduced cholesterol (TC), triglycerides (TAG), and inflammatory markers (MCP‐1, VCAM‐1, IL‐6, IL‐1β, TNFα, NF‐κB) in both preventative and treatment groups. In addition, heart tissue displayed near‐normal collagen fiber distribution. LC‐HRESIMS analysis tentatively identified 20 metabolites ( 1–20 ) in OEN, including lignans, secoiridoids, and triterpenoids. Network pharmacology analysis suggested 8‐hydroxy‐ p ‐menth‐1‐en‐7‐oic‐acid ( 13 ), 6,7‐dihydroxy‐2 H ‐1‐benzopyran‐2‐one 6‐ O ‐ d ‐glucopyranoside ( 5 ), and 3‐hydroxy‐12‐oleanen‐28‐oic‐acid ( 20 ) as key antihyperlipidemic compounds, potentially targeting pathways involved in hyperlipidemia regulation. Furthermore, in silico studies revealed that lignans (compounds 1 , 2 , and 16 ) from OEN may bind and inhibit HMG‐CoA reductase, a crucial enzyme in cholesterol metabolism. These results indicate the potential of using OEN leaf extract as a therapeutic strategy for managing hyperlipidemia and inflammation associated with obesity. More investigation is necessary to confirm and validate these results and explore the extract's full therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasHypolipidemic AgentsInflammationObesityOleaPlant ExtractsPlant LeavesAnimalsMaleRabbitsNetwork PharmacologyTriterpenes

Stichwörter der Autor:innen

MCP‐1Olea europaeaVCAM‐1adiponectinobesity

Substanzen

Hypolipidemic AgentsPlant ExtractsTriterpenes

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Deraya University, New Minia, Egypt.
  • Department of Pathology, Faculty of Pharmacy, Deraya University, New Minia, Egypt.
  • Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
  • Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.

ORCID-Profile: Faisal Alsenani, Abeer H Elmaidomy, Rania Alaaeldin, Nehad M Reda Abdel-Maqsoud, Faisal H Altemani, Naseh A Algehainy, Mubarak A Alzubaidi, Hussain T Bakhsh, Fatma Alzahraa Mokhtar, Mahmoud A Elrehany, Ahmed M Sayed, Mohammad M Al-Sanea, Gerhard Bringmann, Usama Ramadan Abdelmohsen, Ghada M Abbas

Zitieren

APA

Alsenani, F., Elmaidomy, A. H., Alaaeldin, R., Abdel-Maqsoud, N. M. R., Altemani, F. H., Algehainy, N. A., Alzubaidi, M. A., Bakhsh, H. T., Mokhtar, F. A., Elrehany, M. A., Sayed, A. M., Al-Sanea, M. M., Bringmann, G., Abdelmohsen, U. R., & Abbas, G. M. (2025). Olea europaea L. cv. Nepal Leaf Extract Alleviates Dyslipidemia and Inflammation Related to Obesity in Rabbits: A Network Pharmacology Approach Revealing Effective Antihyperlipidemic Bioactive Compounds. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402110

Vancouver

Alsenani F, Elmaidomy AH, Alaaeldin R, Abdel-Maqsoud NMR, Altemani FH, Algehainy NA, et al. Olea europaea L. cv. Nepal Leaf Extract Alleviates Dyslipidemia and Inflammation Related to Obesity in Rabbits: A Network Pharmacology Approach Revealing Effective Antihyperlipidemic Bioactive Compounds. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402110

BibTeX
@article{Alsenani2025,
  author = {Alsenani, Faisal and Elmaidomy, Abeer H and Alaaeldin, Rania and Abdel-Maqsoud, Nehad M Reda and Altemani, Faisal H and Algehainy, Naseh A and Alzubaidi, Mubarak A and Bakhsh, Hussain T and Mokhtar, Fatma Alzahraa and Elrehany, Mahmoud A and Sayed, Ahmed M and Al-Sanea, Mohammad M and Bringmann, Gerhard and Abdelmohsen, Usama Ramadan and Abbas, Ghada M},
  title = {Olea europaea L. cv. Nepal Leaf Extract Alleviates Dyslipidemia and Inflammation Related to Obesity in Rabbits: A Network Pharmacology Approach Revealing Effective Antihyperlipidemic Bioactive Compounds},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202402110}
}
Kostenlos starten →